Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for Nda Filing of Anaphylm™
Aquestive Therapeutics就最近FDA批准的非注射性腎上腺素過敏治療產品發表評論，並重申對Anaphylm™ NDA申請的預期時間。
